A study to identify the diagnostic and prognostic biomarkers of disease development and progression in multiple sclerosis
Simon G Gregory PhD, Principal Investigator
This study is aimed at collecting biological samples from individuals with MS independent of sub-type as a means of identifying biological markers of MS development and progression.
Persons over age 18 who have been diagnosed with MS are eligible.
Participants contribute a blood and urine sample at enrollment into the MURDOCK Study in addition to a medical questionnaire about their general health and a second questionnaire pertaining to their MS diagnosis. A total study visit is estimated to take approximately 45-60 minutes. A sub-study of the project involves the collection of biospecimens from individuals with Primary Progressive MS. These individuals will be asked to provide biological samples biannually for 5 years as well as completing a follow-up questionnaire at each visit.
All persons enrolling in the MS study also enroll in the MURDOCK Study. Persons with MS who have already joined the MURDOCK Study are encouraged to enroll in this MS study.
For more information, please call (704) 250-5861 to learn more about enrolling.